APGE
Price
$36.85
Change
+$0.32 (+0.88%)
Updated
Apr 25 closing price
Capitalization
2.14B
22 days until earnings call
ELVN
Price
$18.21
Change
-$0.09 (-0.49%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
892.37M
11 days until earnings call
Ad is loading...

APGE vs ELVN

Header iconAPGE vs ELVN Comparison
Open Charts APGE vs ELVNBanner chart's image
Apogee Therapeutics
Price$36.85
Change+$0.32 (+0.88%)
Volume$578.75K
Capitalization2.14B
Enliven Therapeutics
Price$18.21
Change-$0.09 (-0.49%)
Volume$3.6K
Capitalization892.37M
APGE vs ELVN Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. ELVN commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and ELVN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (APGE: $36.53 vs. ELVN: $18.30)
Brand notoriety: APGE and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 0% vs. ELVN: 91%
Market capitalization -- APGE: $2.14B vs. ELVN: $892.37M
APGE [@Biotechnology] is valued at $2.14B. ELVN’s [@Biotechnology] market capitalization is $892.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, both APGE and ELVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 6 TA indicator(s) are bullish while ELVN’s TA Score has 6 bullish TA indicator(s).

  • APGE’s TA Score: 6 bullish, 4 bearish.
  • ELVN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а +10.33% price change this week, while ELVN (@Biotechnology) price change was +10.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -4.17%, and the average quarterly price growth was -12.27%.

Reported Earning Dates

APGE is expected to report earnings on May 19, 2025.

ELVN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.14B) has a higher market cap than ELVN($892M). ELVN (-18.667) and APGE (-19.360) have similar YTD gains . ELVN has higher annual earnings (EBITDA): -104.24M vs. APGE (-216.68M). APGE has more cash in the bank: 521M vs. ELVN (313M). ELVN has less debt than APGE: ELVN (0) vs APGE (11.8M). APGE (0) and ELVN (0) have equivalent revenues.
APGEELVNAPGE / ELVN
Capitalization2.14B892M240%
EBITDA-216.68M-104.24M208%
Gain YTD-19.360-18.667104%
P/E RatioN/AN/A-
Revenue00-
Total Cash521M313M166%
Total Debt11.8M0-
TECHNICAL ANALYSIS
Technical Analysis
APGEELVN
RSI
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 6 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
79%
Bullish Trend 6 days ago
81%
Momentum
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 6 days ago
83%
MACD
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 6 days ago
82%
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA259.518.77
+3.50%
Tesla
SPY546.6911.27
+2.10%
SPDR® S&P 500® ETF
AAPL208.373.77
+1.84%
Apple
BTC.X93943.800000244.687500
+0.26%
Bitcoin cryptocurrency
GME27.08-0.04
-0.15%
GameStop Corp

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with ATXS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
N/A
ATXS - APGE
52%
Loosely correlated
+0.19%
SYRE - APGE
51%
Loosely correlated
+4.99%
ELVN - APGE
50%
Loosely correlated
+2.98%
CRNX - APGE
49%
Loosely correlated
+3.15%
KYMR - APGE
49%
Loosely correlated
+9.32%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+2.98%
ERAS - ELVN
50%
Loosely correlated
-1.41%
APGE - ELVN
49%
Loosely correlated
N/A
ATXS - ELVN
48%
Loosely correlated
+0.19%
DNLI - ELVN
47%
Loosely correlated
+4.17%
CRNX - ELVN
47%
Loosely correlated
+3.15%
More